Protocol · Eating pattern
Extra virgin olive oil
B+
Headline grade
Fewer major cardiovascular events in a Mediterranean diet supplemented with extra virgin olive oil
Evidence type: Randomized trials
The graded dose: Extra virgin olive oil used as the primary added fat in a Mediterranean-style eating pattern, about 4 tablespoons (about 50 mL) a day, the PREDIMED intervention pattern (1 liter a week supplied; measured intake about 50 g a day). The evidence attaches to EVOO inside that dietary pattern, not to oil added on top of an unchanged diet.. Frequency in the evidence: undefined sessions per week. The grade attaches to this dose; below it, the grade does not apply.
The caveat: The popular claim (olive oil as a longevity food) is graded through the mortality cohorts at B-: the association is consistent and dose-graded, and it is still an association between an oil and the kind of diet and life that comes with it.
Add this to a build, then take the build to your AI.
Time cost
0 minutes / week
Eating pattern: the oil is used inside meals already being cooked; no separate time cost.
Dollar cost
About $25 / month
$15 to $35/mo at the studied intake (about 1.5 liters a month of genuine extra virgin oil at typical retail) (basis: food)
Every claim, graded
Each outcome this protocol is claimed to deliver carries its own grade and its own kind of evidence. A strong secondary outcome never launders a weak popular claim: the popular claim prints at its own grade, next to the headline.
Outcomes at a glance
Fewer major cardiovascular events (heart attack, stroke, cardiovascular death) in high-risk adults
Lower all-cause and cardiovascular mortality at higher habitual intakes
Anti-inflammatory and metabolic marker improvements (the popular longevity framing)
Popular claim, graded on its own evidenceBar length is the outcome's evidence grade on the house scale: A is 4.0 points, B is 3.0, C is 2.0, D is 1.0. The table below carries the evidence type and what the data show for each row.
| Claim | Grade | Evidence | What the data show |
|---|---|---|---|
| Fewer major cardiovascular events (heart attack, stroke, cardiovascular death) in high-risk adults | B+ | rctRandomized trials | PREDIMED (n=7,447, high-risk primary prevention, median 4.8 years): Mediterranean diet plus EVOO vs control diet, HR 0.69 (0.53 to 0.91) for the composite endpoint (Estruch et al., NEJM 2013; republished 2018 after randomization irregularities at one site were corrected, effect intact). CORDIOPREV (n=1,002, secondary prevention, 7 years): Mediterranean diet rich in EVOO vs low-fat diet, HR 0.73 (Delgado-Lista et al., 2022). Two randomized trials of the dietary pattern carry the grade; the grade stops at B+ because the intervention is a pattern with EVOO as its fat, not EVOO alone, and one trial carries a republication history.Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 2018 (republished; original 2013).; Delgado-Lista J et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV). Lancet Diabetes and Endocrinology, 2022. |
| Lower all-cause and cardiovascular mortality at higher habitual intakes | B- | cohortCohort (observational) | Pooled US cohorts (Nurses' Health Study and Health Professionals Follow-up, n=92,383): consuming more than 7 g a day vs never or rarely, HR 0.81 for total mortality, with substitution models estimating larger effects when olive oil replaces butter or margarine (Guasch-Ferre et al., JACC 2022). Observational, with the healthy-pattern confounding that follows people who cook with olive oil; capped accordingly.Guasch-Ferre M et al. Consumption of olive oil and risk of total and cause-specific mortality among US adults. Journal of the American College of Cardiology, 2022. |
| Anti-inflammatory and metabolic marker improvements (the popular longevity framing)Popular claim, graded on its own evidence | C+ | rctRandomized trials | Smaller trials and PREDIMED substudies report modest improvements in inflammatory and glycemic markers at pattern doses. Marker movement without an outcome trial of its own; the longevity claim as sold rests on the mortality cohorts above, already graded, and polyphenol content varies widely by oil and harvest, which no trial in this base standardized.Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 2018 (republished; original 2013). |
Dose and response
PREDIMED's effect was measured at roughly 50 g a day replacing other fats. Cohort dose-response (Guasch-Ferre 2022) shows the mortality association strengthening from low intakes up to about half a tablespoon to a tablespoon a day and beyond, but no trial isolates an olive-oil-only dose; below the Mediterranean-pattern dose the grade weakens to the cohort association alone.
Equipment that can deliver this dose: . None.
Harms and cautions
Harms live in this ledger, not inside the grade: the grade is evidence for the claimed outcomes in the studied population.
Medication interactions
No medication classes are flagged in this graded record.
Goal conflicts and timing
No goal conflicts in this record.
Daily use as the primary added fat; no timing rule in the evidence.
Population exclusions and other cautions
Calorie addition without substitution: at about 120 kcal a tablespoon, the studied benefit pattern replaces other fats; adding 4 tablespoons on top of an unchanged diet adds roughly 480 kcal a day toward weight gain, which runs against the outcomes graded here moderate
Applies to add-on use, not the replacement pattern in the trials
Source: Composition data; PREDIMED design (oil supplied as the pattern's fat)
Quality and adulteration variance: a meaningful share of retail oil sold as extra virgin fails extra-virgin standards in sampling studies, and polyphenol content varies by harvest and storage, so the product bought may not match the intervention oil minor
A quality caveat, not a safety finding; no toxicity signal attaches to olive oil as a food
Source: UC Davis Olive Center sampling reports, 2010 to 2011 and successors
Can you measure it yourself?
No self-experiment is offered for this record's headline outcomes. DRAFT for Growth integration, graded by Research 2026-10-29 under the food-class handling (a food never borrows a supplement's grade). Headline B+ on cardiovascular events from two randomized dietary-pattern trials; PREDIMED's 2018 republication is disclosed in the outcome text itself, where a reader weighing the grade will see it.
Goals served
Heart health, Longevity
Derived from outcomes grading B- or better, never hand-assigned.
Experience gate
beginner and up (none)
Applicability
broad
Applies broadly, across goals and populations.
Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.
Longevity Lab Report
Protocol news. Graded when it happens.
The grades on this page stay free. The email is the week's longevity and biohacking news in plain English: expert moves, what is working, and new supplements and peptides, each story linked to the grades on this site.
Frequently asked questions
What grade does Extra virgin olive oil get?
At the studied dose (Extra virgin olive oil used as the primary added fat in a Mediterranean-style eating pattern, about 4 tablespoons (about 50 mL) a day, the PREDIMED intervention pattern (1 liter a week supplied; measured intake about 50 g a day). The evidence attaches to EVOO inside that dietary pattern, not to oil added on top of an unchanged diet.), Extra virgin olive oil grades B+ for fewer major cardiovascular events in a mediterranean diet supplemented with extra virgin olive oil, on randomized trials. The grade attaches to that dose; below it, the grade does not apply.
How much time does Extra virgin olive oil take each week?
At the graded dose: Eating pattern: the oil is used inside meals already being cooked; no separate time cost. Dollar cost: $15 to $35/mo at the studied intake (about 1.5 liters a month of genuine extra virgin oil at typical retail).
Does Extra virgin olive oil deliver its most popular claim?
The popular claim (Anti-inflammatory and metabolic marker improvements) grades C+. Smaller trials and PREDIMED substudies report modest improvements in inflammatory and glycemic markers at pattern doses. Marker movement without an outcome trial of its own; the longevity claim as sold rests on the mortality cohorts above, already graded, and polyphenol content varies widely by oil and harvest, which no trial in this base standardized.
Sources
- Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 2018 (republished; original 2013). (2018)
- Delgado-Lista J et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV). Lancet Diabetes and Endocrinology, 2022. (2022)
- Guasch-Ferre M et al. Consumption of olive oil and risk of total and cause-specific mortality among US adults. Journal of the American College of Cardiology, 2022. (2022)
Changelog
Last reviewed October 29, 2026
- 2026-10-29|Initial grading: extra virgin olive oil graded as a whole-food record from the PREDIMED and CORDIOPREV randomized trials and the pooled US mortality cohorts. Cardiovascular events grade B+ (the intervention is a dietary pattern with olive oil as its fat, not the oil alone); mortality B- on cohort evidence; the popular longevity framing is carried by those graded outcomes, not by polyphenol claims.
- 2026-10-29|Integration completion (Growth, 2026-10-29): per-outcome sources added from the record-level source list, mapped by the trials each outcome text names (cardiovascular events: PREDIMED and CORDIOPREV; mortality: the pooled US cohorts; markers: the PREDIMED substudies). The draft carried record-level sources only, and the protocol page reads outcome sources directly. Flagged to Research for verification the same hour; no graded field changed.